Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and effect of memantine on PTSD: open-label extension
jRCTs031230484Recruiting
- Sponsor
- National Center of Neurology and Psychiatry
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of memantine in post-traumatic stress disorder (PTSD), sponsored by National Center of Neurology and Psychiatry. Primary endpoint: Adverse events and safety profile. Started Feb 2024; status: recruiting.
02
Drugs
memantine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on jRCTs031230484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230484.